10-K405/A 1 0001.txt AMENDMENT NO. 1 TO FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2000 or -------------- [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number 0-5286 ------ KEWAUNEE SCIENTIFIC CORPORATION ------------------------------- (Exact name of registrant as specified in its charter) Delaware 38-0715562 ------------------------------- --------------------------------- (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) 2700 West Front Street Statesville, North Carolina 28677-2927 ------------------------------- --------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (704) 873-7202 -------------- Securities registered pursuant to Section 12(b) of the Act: None ---- Securities registered pursuant to Section 12(g) of the Act: Common Stock $2.50 par value ---------------------------- (Title of Class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ----- ----- Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X] The aggregate market value of 1,799,309 shares of voting stock held by non- affiliates of the Registrant was approximately $23,391,017 based on the last reported sale price of the Registrant's Common Stock on July 7, 2000. (Only shares beneficially owned by directors of the Registrant (excluding shares subject to options) were excluded as shares held by affiliates. By including or excluding shares owned by anyone, the Registrant does not admit for any other purpose that any person is or is not an affiliate of the Registrant.) As of July 7, 2000, the Registrant had outstanding 2,465,871 shares of Common Stock. Kewaunee Scientific Corporation Form 10-K/A Annual Report For the Fiscal Year Ended April 30, 2000 This amendment on Form 10-K/A to the Company's Form 10-K for the fiscal year ended April 30, 2000 solely includes a new Exhibit 13.1 which corrects, replaces and supersedes page 22 of the Company's Annual Report to Stockholders which was previously filed as Exhibit 13 to the Company's Form 10-K. The corrected page 22 of the Annual Report to Stockholders merely corrects the historical high and low prices of the Company's Common Stock for fiscal year 2000. SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION By: /s/ Eli Manchester, Jr. ------------------------------------ Eli Manchester, Jr. Chairman and Chief Executive Officer Date: August 4, 2000 2 KEWAUNEE SCIENTIFIC CORPORATION Exhibit Index -------------
Page Number (or Reference) -------------- 13.1 Page 22 of the Annual Report to Stockholders for the fiscal year ended April 30, 2000
3